| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |